During the past decade, Pacific Health Research & Education Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Health Research & Education Institute" #1 sponsor was "GRADE Study Group" with 2 trials, followed by "University of Rochester" with 2 trials sponsored, "Indiana University School of Medicine" with 1 trials sponsored, "James BOYD MD" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Health Research & Education Institute" #1 collaborator was "Michael J. Fox Foundation for Parkinson's Research" with 3 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator, "The Parkinson Study Group" with 2 trials as a collaborator and "American College of Radiology Imaging Network" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Health Research & Education Institute" are "Parkinson Disease" (2 trials), "Parkinson's Disease" (2 trials), "Type 2 Diabetes" (2 trials), "Alzheimer's Disease" (1 trials) and "Comparative Effectiveness of Glycemia-lowering Medications" (1 trials). Many other conditions were trialed in "Pacific Health Research & Education Institute" in a lesser frequency.

Most popular intervention types in "Pacific Health Research & Education Institute" are "Drug" (4 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capillary HbA1c collection" (1 trials), "DPP-4 inhibitor (sitagliptin)" (1 trials), "GLP-1 receptor agonist (liraglutide)" (1 trials), "Insulin (glargine)" (1 trials) and "Isradipine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Health Research & Education Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Pacific Health Research & Education Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Pacific Health Research & Education Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Health Research & Education Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".